BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7863359)

  • 1. Forming and reforming the market for third-party purchasing of health care: a German perspective.
    Graf von der Schulenburg JM
    Soc Sci Med; 1994 Nov; 39(10):1473-81. PubMed ID: 7863359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the sickness funds in the Belgian health care market.
    Nonneman W; van Doorslaer E
    Soc Sci Med; 1994 Nov; 39(10):1483-95. PubMed ID: 7863360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. German risk structure compensation: enhancing equity and effectiveness.
    Files A; Murray M
    Inquiry; 1995; 32(3):300-9. PubMed ID: 7591043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk adjustment and risk selection on the sickness fund insurance market in five European countries.
    van de Ven WP; Beck K; Buchner F; Chernichovsky D; Gardiol L; Holly A; Lamers LM; Schokkaert E; Shmueli A; Spycher S; Van de Voorde C; van Vliet RC; Wasem J; Zmora I
    Health Policy; 2003 Jul; 65(1):75-98. PubMed ID: 12818747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Market Concentration in the Statutory Health Insurance of Germany since the Introduction of Free Choice of Sickness Funds].
    Götze R
    Gesundheitswesen; 2016 Nov; 78(11):715-720. PubMed ID: 25760099
    [No Abstract]   [Full Text] [Related]  

  • 6. The German health care system and health care reform.
    Kamke K
    Health Policy; 1998 Feb; 43(2):171-94. PubMed ID: 10177617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The German Central Health Fund-recent developments in health care financing in Germany.
    Göpffarth D; Henke KD
    Health Policy; 2013 Mar; 109(3):246-52. PubMed ID: 23200602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reimbursement and cost containment: a German perspective.
    Breyer F
    Pharmacoeconomics; 2002; 20 Suppl 3():87-94. PubMed ID: 12457429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Price elasticities in the German Statutory Health Insurance market before and after the health care reform of 2009.
    Pendzialek JB; Danner M; Simic D; Stock S
    Health Policy; 2015 May; 119(5):654-63. PubMed ID: 25670009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk adjustment in Switzerland.
    Beck K; Spycher S; Holly A; Gardiol L
    Health Policy; 2003 Jul; 65(1):63-74. PubMed ID: 12818746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition.
    Busse R; Blümel M; Knieps F; Bärnighausen T
    Lancet; 2017 Aug; 390(10097):882-897. PubMed ID: 28684025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supervision in social health insurance: a four country study.
    Maarse H; Paulus A; Kuiper G
    Health Policy; 2005 Mar; 71(3):333-46. PubMed ID: 15694500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reforming the Israeli health system: findings of a 3-year evaluation.
    Gross R; Rosen B; Shirom A
    Health Policy; 2001 Apr; 56(1):1-20. PubMed ID: 11230905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care über alles: how it works in Germany.
    Rublee DA
    Healthc Financ Manage; 1992 Jan; 46(1):40, 42, 44-7. PubMed ID: 10145559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysing the impact of health-care system change in the EU member states--Germany.
    Wörz M; Busse R
    Health Econ; 2005 Sep; 14(Suppl 1):S133-49. PubMed ID: 16161188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Competition among health insurers from the perspective of a statutory health insurance company].
    Fischer B
    Z Evid Fortbild Qual Gesundhwes; 2009; 103(10):635-8; discussion 643. PubMed ID: 20120192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk-adjusted capitation payments: developing a diagnostic cost groups classification for the Dutch situation.
    Lamers LM
    Health Policy; 1998 Jul; 45(1):15-32. PubMed ID: 10183010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-adjusted capitation. The Israeli experience.
    Shmueli A; Chinitz D
    Eur J Public Health; 2001 Jun; 11(2):182-4. PubMed ID: 11420807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has solidarity survived? A comparative analysis of the effect of social health insurance reform in four European countries.
    Maarse H; Paulus A
    J Health Polit Policy Law; 2003 Aug; 28(4):585-614. PubMed ID: 12956517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.